期刊文献+

Copper metabolism after living related liver transplantation for Wilson's disease 被引量:7

Copper metabolism after living related liver transplantation for Wilson's disease
暂未订购
导出
摘要 AlM: Liver transplantation is indicated for Wilson's disease(WD) patients with the fulminant form and end-stage liverfailure. The aim of this study was to review our experiencewith living-related liver transplantation (LRLT) for WD.METHODS: A retrospective review was made for WDundergoing LRLT at our hospital from January 2001 toFebuary 2003.RESULTS: LRLT was carried out in 15 patients with WD,one of them had fulminant hepatic failure and the others had end-stage hepatic insufficiency. The mean age of the patients was 14.5±2.5 years (range 6 to 20 years). All the recipients had low serum ceruloplasmin levels with a mean value of 126.8±34t.8 mg/L before transplantation. The serum ceruloplasmin levels increased to an average of 238.6±34.4mg/L after LRLT at the latest evaluation, between 2 and 27months after transplantation. A marked reduction in urinary copper excretion was observed in all the recipients after transplantation. Among the eight recipients with preoperative Kayser-Fleischer (K-F) rings, this abnormality resolved completely after LRLT in five patients and partially in three.All the recipients are alive and remain well, and none has developed signs of recurrent WD after a mean follow-up period of 15.4±9.3 months (range 2-27 months) except one who died of severe rejection. The donors were 14t mothers and 1 father. The serum ceruloplasmin levels were within normal limits in all the donors (mean: 220±22.4 mg/L). The mean donor age was 35.0±4.0 years (range, 30 to 45 years).Two donors had biliary leakage and required reoperation.Grafts were harvested as follows: four right lobe grafts without hepatic middle vein and eleven left lobe grafts with hepatic middle vein. The grafts were blood group-compatible in all recibents. Two patients had hepatic artery thrombosis and underwent retransplantation.CONCLUSION: LRLT is a curative procedure in Wilson's disease manifested as fulminant hepatic failure and/or endstage hepatic insufficiency. After liver transplantation, the serum ceruoplasmin level can increase to its normal range while urinary copper excretion decreases. Grafts chosen from heterozygote carriers do not appear to confer any risk of recurrence in recipients. AIM:Liver transplantation is indicated for Wilson's disease (WD)patients with the fulminant form and end-stage liver failure.The aim of this study was to review our experience with living-related liver transplantation(LRLT)for WD, METHODS:A retrospective review was made for WD undergoing LRLT at our hospital from January 2001 to Febuary 2003. RESULTS:LRLT was carried out in 15 patients with WD, one of them had fulminant hepatic failure and the others had end-stage hepatic insufficiency.The mean age of the patients was 14.5±2.5 years(range 6 to 20 years).All the recipients had low serum ceruloplasmin levels with a mean value of 126.8±34.8 mg/L before transplantation.The serum ceruloplasmin levels increased to an average of 238.6±34.4 mg/L after LRLT at the latest evaluation,between 2 and 27 months after transplantation.A marked reduction in urinary copper excretion was observed in all the recipients after transplantation.Among the eight recipients with preoperative Kayser-Fleischer(K-F)rings,this abnormality resolved completely after LRLT in five patients and partially in three. All the recipients are alive and remain well,and none has developed signs of recurrent WD after a mean follow-up period of 15.4±9.3 months(range 2-27 months)except one who died of severe rejection.The donors were 14 mothers and 1 father.The serum ceruloplasmin levels were within normal limits in all the donors(mean:220±22.4 mg/L).The mean donor age was 35.0±4.0 years(range,30 to 45 years). Two donors had biliary leakage and required reoperation. Grafts were harvested as follows:four right lobe grafts without hepatic middle vein and eleven left lobe grafts with hepatic middle vein.The grafts were blood group-compatible in all recipents.Two patients had hepatic artery thrombosis and underwent retransplantation.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第12期2836-2838,共3页 世界胃肠病学杂志(英文版)
基金 the-Basic Research Program Foundation of Jiangsu Province,No.B J98025
  • 相关文献

参考文献31

  • 1[1]Bellary S, Hassanein T, Van Thiel DH. Liver transplantation for Wilson's disease. J Heptol 1995; 23:373-381
  • 2[2]Sternlieb I. Wilson's disease: indications for liver transplants. Hepatology 1984; 4(Suppl): 15s-17s
  • 3[3]Emre S, Atillasoy EO, Ozdemir S, Schilsky M, Rathna Varma CV, Thung SN, Sternlieb I, Guy SR, Sheiner PA, Schwartz ME,Miller CM. Orthotopic liver transplantation for Wilson's disease:a single-center experience. Transplantation 2001; 72:1232-1236
  • 4[4]Burdelski M, Rogiers X. Liver transplantation in metabolic disorders. Acta Gastroenterol Belg 1999; 62:300-305
  • 5[5]Komatsu H, Fujisawa T, Inui A, Sogo T, Sekine I, Kodama H, Uemoto S, Tanaka K. Hepatic copper concentration in children undergoing living related liver transplantation due to Wilsonian fulminant hepatic failure. Clin Transplant 2002; 16:227-232
  • 6[6]Tanaka K, Uemoto S, Inomata Y, Tokunaga Y, Ueda M, Tokka A, Sato B, Yamaoka Y. Living-related liver transplantation for fulminant hepatic failure in children. Transpl Int 1994; 7(Suppl1): S108-110
  • 7[7]Tanaka K, Uemoto S, Tokunaga Y, Fujita S, Sano K, Yamamoto E, Sugano M, Awane M, Yamaoka Y, Kumada K. Living related liver transplantation in children. Am J Surg 1994; 168:41-48
  • 8[8]Asonuma K, Inomata Y, Kasahara M, Uemoto S, Egawa H, Fujita S, Kiuchi T, Hayashi M, Tanaka K. Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease. Pediatr Transplant 1999; 3:201-205
  • 9[9]Terajima H, Tanaka K, Okajima K, Inomata Y, Yamaoka Y. Timing of transplantation and donor selection in living related liver transplantation for fulminant Wilson's disease. Transplant Proc 1995; 27:1177-1178
  • 10[10]Wang X, Zhang F, Li X, Qian J, Kong L, Huang J, Huang Z, Zhang H, Li G, Cheng F, Wang K, Lu S. A clinical report of 12 casetimes of living related liver transplantation. Zhonghua Yixue Zazhi 2002; 82:435-439

同被引文献35

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部